Nagashima-type palmoplantar keratosis in Finland caused by a SERPINB7 founder mutation

Affiliations

• ¹ Department of Dermatology, Skin and Allergy Hospital, University of Helsinki, ERN-skin, and Helsinki University Hospital, Helsinki, Finland; Folkhälsan Research Center, Helsinki, and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Folkhälsan Institute of Genetics, Helsinki, and Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland. Electronic address: katariina.hannula-jouppi@hus.fi.
• ² Department of Dermatology, Skin and Allergy Hospital, University of Helsinki, ERN-skin, and Helsinki University Hospital, Helsinki, Finland.
• ³ Folkhälsan Research Center, Helsinki, and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Folkhälsan Institute of Genetics, Helsinki, and Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden; Science for Life Laboratory, Department of Gene Technology, KTH-Royal Institute of Technology, Solna, Sweden.
• ⁴ Folkhälsan Research Center, Helsinki, and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Folkhälsan Institute of Genetics, Helsinki, and Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland.
• ⁵ Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland; Laboratory of Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
• ⁶ Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland; Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway.
• ⁷ PEDEGO Research Unit, University of Oulu and the Department of Dermatology and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.
• ⁸ Departments of Clinical Genetics and Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
• ⁹ Rare Disease Center, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
• ¹⁰ Folkhälsan Research Center, Helsinki, and Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Folkhälsan Institute of Genetics, Helsinki, and Research Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden; School of Basic and Medical Biosciences, King's College London, London, United Kingdom.